Electronics testing equipment maker Agilent Technologies Inc, backed by Sweden-based private equity group EQT, would buy Denmark-based cancer diagnostics company Dako for $2.2 billion in cash.
The deal, which is expected to close in two months, will immediately add to Agilent's adjusted earnings, Agilent said.
Dako provides antibodies, reagents, scientific instruments and software mainly to customers in pathology laboratories.
This article is copyrighted by Reuters
Join the Conversation